Clinical Trial Update: A Clinical Study Evaluating the Replacement of the Native Mitral Valve Using the ReValve System [Phase 1]

View source ↗

Summary

A Phase 1 clinical study evaluating the replacement of the native mitral valve using the ReValve System for mitral regurgitation is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Regurgitation

Snippet

Sponsor: ReValve Solutions Inc. | Conditions: Mitral Regurgitation | Phase 1 | Status: RECRUITING